Clinical Trial Update: Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the effects of corticosteroids on asymptomatic gadolinium-enhancing lesions in Relapsing-Remitting Multiple Sclerosis; the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Mazandaran University of Medical Sciences | Conditions: Multiple Sclerosis, Relapsing-Remitting, Magnetic Resonance Imaging | Phase 2 | Status: COMPLETED